Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.
Granelli-Piperno A
,
Inaba K
,
Steinman RM
.
???displayArticle.abstract???
Three-day, concanavalin A-induced T lymphoblasts have been used as a model to study lymphokine release from sensitized T cells. The blasts responded to interleukin 2 (IL-2) but did not constitutively produce this or other lymphokines. After mitogen restimulation, blast cells synthesized IL-2 as well as gamma-interferon, B cell-stimulating factor(s), and cytolytic differentiation factor(s). This production resulted from the induction of biologically active lymphokine mRNA. Cyclosporin A (CSA), a potent immunosuppressive agent, strongly inhibited synthesis of IL-2, gamma-interferon, and B cell- and CTL-stimulating factor(s), from mitogen-restimulated T blasts. In contrast, CSA did not block the cytolytic activity of the T blasts, nor modify bulk protein synthesis induced by Con A. CSA also blocked lymphokine release from a phorbol myristate acetate-stimulated thymoma cell line, EL-4. The effect of CSA was to block the induction of active lymphokine mRNA, as assayed in an oocyte translation system. This selective inhibition of lymphokine mRNA suggests that CSA may be useful in the therapy of inflammatory, lymphokine-mediated disease states.
Andrus,
Interleukin 2 production by alloantigen (H-2) activated T cells.
1981, Pubmed
Andrus,
Interleukin 2 production by alloantigen (H-2) activated T cells.
1981,
Pubmed
Andrus,
Inhibition of T-cell activity by cyclosporin A.
1981,
Pubmed
Bleackley,
Translation of lymphocyte mRNA into biologically-active Interleukin 2 in oocytes.
1981,
Pubmed
,
Xenbase
Borel,
Biological effects of cyclosporin A: a new antilymphocytic agent.
1976,
Pubmed
Bunjes,
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.
1981,
Pubmed
Chirgwin,
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
1979,
Pubmed
Farrar,
Thymoma production of T cell growth factor (Interleukin 2).
1980,
Pubmed
Glisin,
Ribonucleic acid isolated by cesium chloride centrifugation.
1974,
Pubmed
Granelli-Piperno,
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.
1981,
Pubmed
Gurdon,
Injected nuclei in frog oocytes: fate, enlargement, and chromatin dispersal.
1976,
Pubmed
,
Xenbase
HALL,
The lymph-borne cells of the immune response.
1963,
Pubmed
Hall,
Studies of the cells in the afferent and efferent lymph of lymph nodes draining the site of skin homografts.
1967,
Pubmed
Hess,
Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
1980,
Pubmed
Howard,
Regulation of B-cell growth and differentiation by soluble factors.
1983,
Pubmed
Inaba,
Dendritic cells induce T lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism.
1983,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
NULL,
Interleukins and lymphocyte activation.
1982,
Pubmed
Pinkston,
Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.
1983,
Pubmed
Schreiber,
Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
1983,
Pubmed
Shidani,
Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s).
1984,
Pubmed
Thomson,
Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.
1983,
Pubmed
Vassalli,
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate.
1977,
Pubmed
Wagner,
T-cell-derived helper factor allows Lyt 123 thymocytes to differentiate into cytotoxic T lymphocytes.
1979,
Pubmed
Wilkins,
The demonstration of an interleukin-2 like activity in the synovial fluids of rheumatoid arthritis patients.
1983,
Pubmed
